PureTech to Present at the SVB Securities Global Biopharma Conference

Author's Avatar
Feb 01, 2023

PureTech+Health+plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Daphne Zohar, Founder and Chief Executive Officer and Eric Elenko, Chief Innovation Officer, will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15 at 10:40am EST. A webcast of the presentation will be available at https%3A%2F%2Finvestors.puretechhealth.com.